Morgan Stanley Maintains Overweight on SI-BONE, Raises Price Target to $23
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and raises the price target from $20 to $23.
Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and raises the price target from $20 to $23.